Skip to main content

. 1993 Jun;86(6):355–356. doi: 10.1177/014107689308600615

Xeroderma pigmentosum variant: 5 years of tumour suppression by etretinate.

J Berth-Jones ¹, J Cole ¹, A R Lehmann ¹, C F Arlett ¹, R A Graham-Brown ¹

PMCID: PMC1294488 PMID: 8315632

355

Images in this article

Figure 1.
on p.355

Figure 1.
on p.356

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Arlett C. F., Harcourt S. A., Cole J., Green M. H., Anstey A. V. A comparison of the response of unstimulated and stimulated T-lymphocytes and fibroblasts from normal, xeroderma pigmentosum and trichothiodystrophy donors to the lethal action of UV-C. Mutat Res. 1992 Mar;273(2):127–135. doi: 10.1016/0921-8777(92)90074-d. [DOI] [PubMed] [Google Scholar]
Cole J., Arlett C. F., Norris P. G., Stephens G., Waugh A. P., Beare D. M., Green M. H. Elevated hprt mutant frequency in circulating T-lymphocytes of xeroderma pigmentosum patients. Mutat Res. 1992 Mar;273(2):171–178. doi: 10.1016/0921-8777(92)90078-h. [DOI] [PubMed] [Google Scholar]
Kraemer K. H., DiGiovanna J. J., Moshell A. N., Tarone R. E., Peck G. L. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med. 1988 Jun 23;318(25):1633–1637. doi: 10.1056/NEJM198806233182501. [DOI] [PubMed] [Google Scholar]
Lehmann A. R., Kirk-Bell S., Arlett C. F., Paterson M. C., Lohman P. H., de Weerd-Kastelein E. A., Bootsma D. Xeroderma pigmentosum cells with normal levels of excision repair have a defect in DNA synthesis after UV-irradiation. Proc Natl Acad Sci U S A. 1975 Jan;72(1):219–223. doi: 10.1073/pnas.72.1.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
Pichler E., Fritsch P. Xeroderma Pigmentosum: Tumorprophylaxe mit Etretinat. Hautarzt. 1984 Mar;35(3):159–161. [PubMed] [Google Scholar]

ACTIONS

RESOURCES